Terms: = Gastric cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
345 results:
1. [Intraperitoneal Transfer of miR-29b Containing Exosome Suppresses the Development of Peritoneal Metastases from gastric cancer].
Kimura Y; Ohzawa H; Kaneko Y; Miyato H; Kurashina K; Saito S; Yamaguchi H; Hosoya Y; Sata N; Kitayama J
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1435-1437. PubMed ID: 38303299
[TBL] [Abstract] [Full Text] [Related]
2. N
Xu P; Liu K; Huang S; Lv J; Yan Z; Ge H; Cheng Q; Chen Z; Ji P; Qian Y; Li B; Xu H; Yang L; Xu Z; Zhang D
Gastric Cancer; 2024 Mar; 27(2):275-291. PubMed ID: 38252226
[TBL] [Abstract] [Full Text] [Related]
3. Hyperthermic intraperitoneal chemotherapy for gastric cancer: a narrative review.
Chen C; Justo M; Gangi A
Chin Clin Oncol; 2023 Dec; 12(6):68. PubMed ID: 38195075
[TBL] [Abstract] [Full Text] [Related]
4. Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study.
Yang Z; Lu S; Shi M; Yuan H; Wang Z; Ni Z; He C; Zheng Y; Zhu Z; Liu W; Yao X; Zhang J; Li C; Yan M; Yan C; Zhu Z
Gastric Cancer; 2024 Mar; 27(2):387-399. PubMed ID: 38143257
[TBL] [Abstract] [Full Text] [Related]
5. miR-4270 suppresses hepatocellular carcinoma progression by inhibiting DNMT3A-mediated methylation of HGFAC promoter.
Zou Q; Cao S
PeerJ; 2023; 11():e16566. PubMed ID: 38077422
[TBL] [Abstract] [Full Text] [Related]
6. [Japanese practice of comprehensive treatment for peritoneal metastasis of gastric cancer].
Liu Y; Yutaka CL; Toshiyuki LX; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):992-996. PubMed ID: 37849272
[TBL] [Abstract] [Full Text] [Related]
7. gastric cancer-derived LBP promotes liver metastasis by driving intrahepatic fibrotic pre-metastatic niche formation.
Xie L; Qiu S; Lu C; Gu C; Wang J; Lv J; Fang L; Chen Z; Li Y; Jiang T; Xia Y; Wang W; Li B; Xu Z
J Exp Clin Cancer Res; 2023 Oct; 42(1):258. PubMed ID: 37789385
[TBL] [Abstract] [Full Text] [Related]
8. SEC23A confers ER stress resistance in gastric cancer by forming the ER stress-SEC23A-autophagy negative feedback loop.
Cheng Q; Liu K; Xiao J; Shen K; Wang Y; Zhou X; Wang J; Xu Z; Yang L
J Exp Clin Cancer Res; 2023 Sep; 42(1):232. PubMed ID: 37670384
[TBL] [Abstract] [Full Text] [Related]
9. Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis.
Wang M; Li J; Yang X; Yan Q; Wang H; Xu X; Lu Y; Li D; Wang Y; Sun R; Zhang S; Zhang Y; Zhang Z; Meng F; Li Y
Cancer Gene Ther; 2023 Nov; 30(11):1485-1497. PubMed ID: 37542132
[TBL] [Abstract] [Full Text] [Related]
10. Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era.
Dermawan JK; Kelly C; Gao Z; Smith S; Jadeja B; Singer S; Tap WD; Chi P; Antonescu CR
Clin Cancer Res; 2023 Oct; 29(19):3974-3985. PubMed ID: 37477937
[TBL] [Abstract] [Full Text] [Related]
11. Eukaryotic Elongation Factor 1Alpha-2 (EEF1A2) Participates in the Progression of gastric cancer via Interaction with Heat Shock Protein B8 (HSPB8).
Li J; Tang X; Zhang Z
Ann Clin Lab Sci; 2023 May; 53(3):398-408. PubMed ID: 37437931
[TBL] [Abstract] [Full Text] [Related]
12. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession.
Guo Z; Guo L
Dig Liver Dis; 2024 Feb; 56(2):352-362. PubMed ID: 37429790
[TBL] [Abstract] [Full Text] [Related]
13. DSC2 suppresses the growth of gastric cancer through the inhibition of nuclear translocation of γ-catenin and PTEN/PI3K/AKT signaling pathway.
Sun C; Wen K; Zhang B; Dong Y; Chen C; Neo SY; Leng B; Gao TT; Wu J
Aging (Albany NY); 2023 Jul; 15(13):6380-6399. PubMed ID: 37421607
[TBL] [Abstract] [Full Text] [Related]
14. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability.
Yang F; Ma Q; Huang B; Wang X; Pan X; Yu T; Ran L; Jiang S; Li H; Chen Y; Liu Y; Liang C; Ren J; Zhang Y; Wang S; Li W; Xiao B
J Transl Med; 2023 Jun; 21(1):402. PubMed ID: 37340423
[TBL] [Abstract] [Full Text] [Related]
15. Anti-apoptotic protein BCL-XL as a therapeutic vulnerability in gastric cancer.
Wei Y; Zhang L; Wang C; Li Z; Luo M; Xie G; Yang X; Li M; Ren S; Zhao D; Gao R; Gong JN
Animal Model Exp Med; 2023 Jun; 6(3):245-254. PubMed ID: 37271936
[TBL] [Abstract] [Full Text] [Related]
16. [Effects of laparoscopic hyperthermic intraperitoneal perfusion chemotherapy combined with intraperitoneal and systemic chemotherapy treatment in patients with untreated gastric cancer with peritoneal metastasis].
Li S; Xue K; Dai HM; Wang YK; Shan F; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):442-447. PubMed ID: 37217352
[No Abstract] [Full Text] [Related]
17. The Generation and Application of Monoclonal Antibodies to Detect SAPCD2 Expression in Precancerous and Malignant gastric Lesions.
Gao F; Chen Y; Zhang W; Wang X; Li J; Feng F; Liu C; He W; Sun W
Iran J Immunol; 2023 May; 20(2):190-201. PubMed ID: 37161922
[TBL] [Abstract] [Full Text] [Related]
18. Surgical Management of Germline Gastrointestinal Stromal Tumor.
Kwak HV; Tardy KJ; Allbee A; Stashek K; DeMatteo RP
Ann Surg Oncol; 2023 Aug; 30(8):4966-4974. PubMed ID: 37115371
[TBL] [Abstract] [Full Text] [Related]
19. Effect of COP1 in Promoting the Tumorigenesis of gastric cancer by Down-Regulation of CDH18 via PI3K/AKT Signal Pathway.
Zhao B; Wu J; Cha X; Mao G; Shi H; Fei S; Miao B
Anal Cell Pathol (Amst); 2023; 2023():5617875. PubMed ID: 37025097
[TBL] [Abstract] [Full Text] [Related]
20. Jianpi Yangzheng decoction suppresses gastric cancer progression via modulating the miR-448/CLDN18.2 mediated YAP/TAZ signaling.
Xu X; Li Y; Zhang R; Chen X; Shen J; Yuan M; Chen Y; Chen M; Liu S; Wu J; Sun Q
J Ethnopharmacol; 2023 Jul; 311():116450. PubMed ID: 37023839
[TBL] [Abstract] [Full Text] [Related]
[Next]
